Longeveron Inc. (LGVN)

USD 1.56

(0.0%)

Revenue Summary of Longeveron Inc.

  • Longeveron Inc.'s latest annual revenue in 2023 was 709 Thousand USD , down -41.98% from previous year.
  • Longeveron Inc.'s latest quarterly revenue in 2024 Q2 was 468 Thousand USD , down -14.6% from previous quarter.
  • Longeveron Inc. reported a annual revenue of 1.22 Million USD in annual revenue 2022, down -6.43% from previous year.
  • Longeveron Inc. reported a annual revenue of 1.3 Million USD in annual revenue 2021, down -76.8% from previous year.
  • Longeveron Inc. reported a quarterly revenue of 548 Thousand USD for 2024 Q1, up 769.84% from previous quarter.
  • Longeveron Inc. reported a quarterly revenue of 217 Thousand USD for 2023 Q2, down -22.22% from previous quarter.

Annual Revenue Chart of Longeveron Inc. (2023 - 2018)

Historical Annual Revenue of Longeveron Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 709 Thousand USD -41.98%
2022 1.22 Million USD -6.43%
2021 1.3 Million USD -76.8%
2020 5.62 Million USD -0.18%
2019 5.63 Million USD 164.17%
2018 2.13 Million USD 0.0%

Peer Revenue Comparison of Longeveron Inc.

Name Revenue Revenue Difference
Sangamo Therapeutics, Inc. 176.23 Million USD 99.598%
IDEAYA Biosciences, Inc. 23.38 Million USD 96.968%
Eton Pharmaceuticals, Inc. 31.64 Million USD 97.759%
Autolus Therapeutics plc 1.69 Million USD 58.245%
Greenwich LifeSciences, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 57.212%
LENZ Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. 7.14 Million USD 90.077%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Aptose Biosciences Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 98.545%
Dyadic International, Inc. 2.89 Million USD 75.542%
TScan Therapeutics, Inc. 21.04 Million USD 96.632%
Intensity Therapeutics, Inc. - USD -Infinity%
Nektar Therapeutics 90.12 Million USD 99.213%
CytomX Therapeutics, Inc. 101.21 Million USD 99.3%
VYNE Therapeutics Inc. 424 Thousand USD -67.217%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 98.459%
Leap Therapeutics, Inc. - USD -Infinity%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.584%
GRI Bio, Inc. 21.76 Million USD 96.743%
Xenetic Biosciences, Inc. 2.53 Million USD 72.086%
Tenaya Therapeutics, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
Psyence Biomedical Ltd. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 66.714%
INmune Bio, Inc. 155 Thousand USD -357.419%
Opthea Limited 261.85 Thousand USD -170.756%
Milestone Pharmaceuticals Inc. 1 Million USD 29.1%
Omega Therapeutics, Inc. 3.09 Million USD 77.085%
Verastem, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 79.743%
Pliant Therapeutics, Inc. 1.58 Million USD 55.127%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 90.873%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.46%
NextCure, Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -172.169%
Organovo Holdings, Inc. 109 Thousand USD -550.459%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Arvinas, Inc. 78.5 Million USD 99.097%
Ovid Therapeutics Inc. 391.69 Thousand USD -81.008%
CASI Pharmaceuticals, Inc. 33.87 Million USD 97.907%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 89.654%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.551%
Syros Pharmaceuticals, Inc. 9.93 Million USD 92.864%
Senti Biosciences, Inc. 2.56 Million USD 72.316%
BioRestorative Therapies, Inc. 145.8 Thousand USD -386.283%
Apollomics, Inc. 821 Thousand USD 13.642%
PureTech Health plc 3.33 Million USD 78.709%
Oncternal Therapeutics, Inc. 785 Thousand USD 9.682%
Barinthus Biotherapeutics plc 802 Thousand USD 11.596%
Kymera Therapeutics, Inc. 78.59 Million USD 99.098%
Synaptogenix, Inc. - USD -Infinity%
ChromaDex Corporation 83.57 Million USD 99.152%
Beam Therapeutics Inc. 377.7 Million USD 99.812%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.636%
Nurix Therapeutics, Inc. 76.98 Million USD 99.079%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.821%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 46.732%
Mesoblast Limited 5.9 Million USD 87.987%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.567%
Fate Therapeutics, Inc. 63.53 Million USD 98.884%
MediWound Ltd. 18.68 Million USD 96.206%
BioXcel Therapeutics, Inc. 1.38 Million USD 48.623%
Fortress Biotech, Inc. 84.51 Million USD 99.161%
Fractyl Health, Inc. Common Stock 120 Thousand USD -490.833%
Achilles Therapeutics plc - USD -Infinity%
Seres Therapeutics, Inc. 126.32 Million USD 99.439%
Checkpoint Therapeutics, Inc. 103 Thousand USD -588.35%
Atossa Therapeutics, Inc. - USD -Infinity%
Zai Lab Limited 266.71 Million USD 99.734%
Fresh Tracks Therapeutics, Inc. 8 Million USD 91.144%
Lyell Immunopharma, Inc. 130 Thousand USD -445.385%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.632%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 95.936%
InMed Pharmaceuticals Inc. 4.59 Million USD 84.579%
FibroGen, Inc. 147.75 Million USD 99.52%
Celcuity Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.753%
GH Research PLC - USD -Infinity%
HOOKIPA Pharma Inc. 20.12 Million USD 96.478%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -68.81%
ImmuCell Corporation 17.47 Million USD 95.942%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.814%
Amarin Corporation plc 306.91 Million USD 99.769%
TG Therapeutics, Inc. 233.66 Million USD 99.697%
Aptevo Therapeutics Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Foghorn Therapeutics Inc. 34.15 Million USD 97.924%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.164%
Aptorum Group Limited 431.37 Thousand USD -64.357%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.837%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.786%
Chemomab Therapeutics Ltd. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.705%
TransCode Therapeutics, Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 99.43%
Ainos, Inc. 122.11 Thousand USD -480.615%
Lyra Therapeutics, Inc. 1.55 Million USD 54.493%
Prothena Corporation plc 91.37 Million USD 99.224%
HilleVax, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 60.28 Million USD 98.824%
Celularity Inc. 22.77 Million USD 96.886%
Rallybio Corporation - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 87.086%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.716%
Cocrystal Pharma, Inc. - USD -Infinity%
Blueprint Medicines Corporation 249.38 Million USD 99.716%
IO Biotech, Inc. - USD -Infinity%
MEI Pharma, Inc. 65.29 Million USD 98.914%
GT Biopharma, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -14080.0%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 97.712%
Scholar Rock Holding Corporation - USD -Infinity%
Pulmatrix, Inc. 7.29 Million USD 90.285%
Elicio Therapeutics, Inc. - USD -Infinity%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 98.045%
Cytokinetics, Incorporated 7.53 Million USD 90.584%
Vor Biopharma Inc. - USD -Infinity%
Evogene Ltd. 5.64 Million USD 87.429%
Replimune Group, Inc. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 92.905%
PDS Biotechnology Corporation - USD -Infinity%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 92.379%
AEON Biopharma, Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 85.229%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD -125.796%
Aerovate Therapeutics, Inc. - USD -Infinity%
VistaGen Therapeutics, Inc. 1.06 Million USD 33.365%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 64.55%
MediciNova, Inc. 1 Million USD 29.1%
Praxis Precision Medicines, Inc. 2.44 Million USD 71.026%
MiMedx Group, Inc. 321.47 Million USD 99.779%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -4054.703%
Axsome Therapeutics, Inc. 270.6 Million USD 99.738%
PTC Therapeutics, Inc. 937.82 Million USD 99.924%
Mereo BioPharma Group plc 10 Million USD 92.91%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Dyne Therapeutics, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Allakos Inc. - USD -Infinity%
scPharmaceuticals Inc. 13.59 Million USD 94.784%
Fulcrum Therapeutics, Inc. 2.8 Million USD 74.724%
Corcept Therapeutics Incorporated 482.37 Million USD 99.853%
NLS Pharmaceutics AG - USD -Infinity%
Precigen, Inc. 6.22 Million USD 88.61%
XOMA Corporation 4.75 Million USD 85.099%
Kezar Life Sciences, Inc. 7 Million USD 89.871%
Incyte Corporation 3.69 Billion USD 99.981%
Alzamend Neuro, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 96.619%
Aligos Therapeutics, Inc. 15.52 Million USD 95.434%
Seer, Inc. 15.18 Million USD 95.33%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.809%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -5779.426%
Akari Therapeutics, Plc - USD -Infinity%
Novavax, Inc. 983.7 Million USD 99.928%
Lexaria Bioscience Corp. 226.2 Thousand USD -213.428%
UroGen Pharma Ltd. 82.71 Million USD 99.143%
Sutro Biopharma, Inc. 153.73 Million USD 99.539%
Entera Bio Ltd. - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 91.925%
Chimerix, Inc. 324 Thousand USD -118.827%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Phathom Pharmaceuticals, Inc. 682 Thousand USD -3.959%
Outlook Therapeutics, Inc. - USD -Infinity%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.982%
AnaptysBio, Inc. 17.15 Million USD 95.868%
Aprea Therapeutics, Inc. 583.23 Thousand USD -21.564%
Portage Biotech Inc. - USD -Infinity%
Olema Pharmaceuticals, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Qualigen Therapeutics, Inc. 5.2 Million USD 86.378%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Processa Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 98.135%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
Daré Bioscience, Inc. 2.8 Million USD 74.75%
Titan Pharmaceuticals, Inc. 184 Thousand USD -285.326%
Bicycle Therapeutics plc 26.97 Million USD 97.372%
Revolution Medicines, Inc. Warrant 11.58 Million USD 93.877%
Protagonist Therapeutics, Inc. 60 Million USD 98.818%
Erasca, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 97.596%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 98.344%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.971%
DBV Technologies S.A. 15.72 Million USD 95.492%
Fortress Biotech, Inc. 84.51 Million USD 99.161%
Avidity Biosciences, Inc. 9.56 Million USD 92.584%
CorMedix Inc. - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.512%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 74.312%
Spruce Biosciences, Inc. 10.08 Million USD 92.973%
Celldex Therapeutics, Inc. 6.88 Million USD 89.699%
Cartesian Therapeutics, Inc. 26 Million USD 97.273%
Cogent Biosciences, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -1112.691%
Ocuphire Pharma, Inc. 19.04 Million USD 96.278%
Prime Medicine, Inc. - USD -Infinity%
Adagene Inc. 18.11 Million USD 96.085%
Inhibrx Biosciences, Inc. 1.8 Million USD 60.611%
GlycoMimetics, Inc. 10 Thousand USD -6990.0%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.755%
Verve Therapeutics, Inc. 11.75 Million USD 93.97%
Voyager Therapeutics, Inc. 250 Million USD 99.716%
SciSparc Ltd. 2.87 Million USD 75.373%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Astria Therapeutics, Inc. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.267%
Tevogen Bio Holdings Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 98.811%
Marker Therapeutics, Inc. 3.31 Million USD 78.587%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.961%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.294%
ADMA Biologics, Inc. 258.21 Million USD 99.725%
Clene Inc. 654 Thousand USD -8.41%
Capricor Therapeutics, Inc. 25.17 Million USD 97.184%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 98.409%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 98.582%
Absci Corporation 5.71 Million USD 87.601%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.995%
Surrozen, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 97.944%
Janux Therapeutics, Inc. 8.08 Million USD 91.229%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 92.736%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.902%
Kronos Bio, Inc. 6.28 Million USD 88.725%
Innoviva, Inc. 310.46 Million USD 99.772%
Bolt Biotherapeutics, Inc. 7.87 Million USD 90.998%
Entrada Therapeutics, Inc. 129.01 Million USD 99.45%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 15.531%
AlloVir, Inc. - USD -Infinity%
Century Therapeutics, Inc. 2.23 Million USD 68.277%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Kura Oncology, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
Mineralys Therapeutics, Inc. - USD -Infinity%
Eterna Therapeutics Inc. 68 Thousand USD -942.647%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Heron Therapeutics, Inc. 127.04 Million USD 99.442%
SAB Biotherapeutics, Inc. 2.23 Million USD 68.334%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 75.051%
C4 Therapeutics, Inc. 20.75 Million USD 96.584%
Atara Biotherapeutics, Inc. 8.57 Million USD 91.73%
Coherus BioSciences, Inc. 257.24 Million USD 99.724%
Lantern Pharma Inc. - USD -Infinity%
Histogen Inc. 3.76 Million USD 81.189%
Surrozen, Inc. - USD -Infinity%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 80.306%
Avalo Therapeutics, Inc. 1.92 Million USD 63.15%
Moderna, Inc. 6.84 Billion USD 99.99%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.91%
Turnstone Biologics Corp. 19.3 Million USD 96.328%
Immix Biopharma, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.596%
Exelixis, Inc. 1.83 Billion USD 99.961%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.374%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.957%
Jasper Therapeutics, Inc. - USD -Infinity%
Arcellx, Inc. 110.31 Million USD 99.357%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.493%
Insmed Incorporated 305.2 Million USD 99.768%
Cardiff Oncology, Inc. 488 Thousand USD -45.287%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.105%
Moolec Science SA 905.04 Thousand USD 21.662%
RenovoRx, Inc. - USD -Infinity%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -199.156%
LAVA Therapeutics N.V. 6.76 Million USD 89.526%
Verrica Pharmaceuticals Inc. 5.12 Million USD 86.163%
Royalty Pharma plc 2.35 Billion USD 99.97%
OmniAb, Inc. 34.16 Million USD 97.925%
Alector, Inc. 97.06 Million USD 99.27%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Mersana Therapeutics, Inc. 36.85 Million USD 98.076%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
Revance Therapeutics, Inc. 234.04 Million USD 99.697%
89bio, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Veracyte, Inc. 361.05 Million USD 99.804%
Genelux Corporation 170 Thousand USD -317.059%
Trevi Therapeutics, Inc. - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -379.686%
Immunovant, Inc. - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.641%
Fortrea Holdings Inc. 3.1 Billion USD 99.977%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Agenus Inc. 156.31 Million USD 99.546%
Acasti Pharma Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Theravance Biopharma, Inc. 57.42 Million USD 98.765%
Metagenomi, Inc. Common Stock 44.75 Million USD 98.416%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Gain Therapeutics, Inc. 55.18 Thousand USD -1184.886%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 54.376%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.084%
United Therapeutics Corporation 2.32 Billion USD 99.97%
Creative Medical Technology Holdings, Inc. 9000.00 USD -7777.778%
BriaCell Therapeutics Corp. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -883.329%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.711%
XOMA Corporation 4.75 Million USD 85.099%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
uniQure N.V. 15.84 Million USD 95.525%
Xilio Therapeutics, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -179.604%
Windtree Therapeutics, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 98.904%
Pluri Inc. 326 Thousand USD -117.485%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
MeiraGTx Holdings plc 14.01 Million USD 94.942%
Cidara Therapeutics, Inc. 63.9 Million USD 98.891%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.822%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 85.808%
Nutriband Inc. 2.08 Million USD 66.0%
Protara Therapeutics, Inc. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 97.881%
Roivant Sciences Ltd. 124.79 Million USD 99.432%
ProKidney Corp. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 58.601%
Tango Therapeutics, Inc. 36.52 Million USD 98.059%
Renovaro Biosciences Inc. - USD -Infinity%
Zevra Therapeutics, Inc. 27.46 Million USD 97.418%
Benitec Biopharma Inc. 216 Thousand USD -228.241%
GeoVax Labs, Inc. - USD -Infinity%
Biomea Fusion, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 96.579%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.738%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 886 Thousand USD 19.977%
Ventyx Biosciences, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -646.316%
Larimar Therapeutics, Inc. - USD -Infinity%
Zura Bio Limited - USD -Infinity%
aTyr Pharma, Inc. 353 Thousand USD -100.85%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD -125.796%
Galecto, Inc. - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.915%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 41.113%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
Forte Biosciences, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.579%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Lexaria Bioscience Corp. 226.2 Thousand USD -213.428%
Instil Bio, Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -4054.703%
OncoCyte Corporation 1.5 Million USD 52.828%
Elevation Oncology, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 93.53%
MacroGenics, Inc. 58.74 Million USD 98.793%
Verona Pharma plc - USD -Infinity%
Tharimmune, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD -9.892%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 92.926%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.971%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 85.569%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.393%
Adicet Bio, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 34.473%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 87.991%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 97.225%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 21.662%
Clearside Biomedical, Inc. 8.22 Million USD 91.381%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.177%
Evaxion Biotech A/S 73.11 Thousand USD -869.745%
Ocular Therapeutix, Inc. 58.44 Million USD 98.787%
Tyra Biosciences, Inc. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 97.089%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.822%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -369.536%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 82.332%
ImmunityBio, Inc. 622 Thousand USD -13.987%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 86.972%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 98.989%
Celularity Inc. 22.77 Million USD 96.886%
Virax Biolabs Group Limited 156.41 Thousand USD -353.27%
Cibus, Inc. 1.81 Million USD 60.98%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 90.102%
Eyenovia, Inc. 3787.00 USD -18621.943%
Puma Biotechnology, Inc. 235.63 Million USD 99.699%
NeurAxis, Inc. 2.46 Million USD 71.179%
Regulus Therapeutics Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 3.389%
Notable Labs, Ltd. 310 Thousand USD -128.71%
IN8bio, Inc. - USD -Infinity%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 61.923%
Lumos Pharma, Inc. 2.05 Million USD 65.431%
Liquidia Corporation 17.48 Million USD 95.946%
Mustang Bio, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 34.473%
Arbutus Biopharma Corporation 18.14 Million USD 96.092%
enGene Holdings Inc. Common Stock - USD -Infinity%
ARS Pharmaceuticals, Inc. 30 Thousand USD -2263.333%
180 Life Sciences Corp. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 98.259%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
Solid Biosciences Inc. - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD -183.6%
Nutriband Inc. 2.08 Million USD 66.0%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -247.549%
GeoVax Labs, Inc. - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
Altimmune, Inc. 426 Thousand USD -66.432%
Peak Bio, Inc. 367.87 Thousand USD -92.727%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.62%
Kintara Therapeutics, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 98.228%
argenx SE 1.22 Billion USD 99.942%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Dianthus Therapeutics, Inc. 2.82 Million USD 74.912%
Immunome, Inc. 14.01 Million USD 94.942%
Enveric Biosciences, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 67.817%
Enliven Therapeutics, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 40.37%
Taysha Gene Therapies, Inc. 15.45 Million USD 95.411%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 14.785%
Athira Pharma, Inc. - USD -Infinity%
XOMA Corporation 4.75 Million USD 85.099%
Merus N.V. 43.94 Million USD 98.387%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD -8.41%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 59.509%
Synlogic, Inc. 3.37 Million USD 78.968%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -92.727%
Werewolf Therapeutics, Inc. 19.94 Million USD 96.445%
Krystal Biotech, Inc. 50.69 Million USD 98.602%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.514%
SpringWorks Therapeutics, Inc. 5.44 Million USD 86.984%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD -57.69%
MannKind Corporation 198.96 Million USD 99.644%
Ikena Oncology, Inc. 9.16 Million USD 92.26%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.375%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.751%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 98.586%
REGENXBIO Inc. 90.24 Million USD 99.214%
Ensysce Biosciences, Inc. 2.23 Million USD 68.214%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 90.392%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 6.093%
Repare Therapeutics Inc. 51.13 Million USD 98.613%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.943%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 93.877%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -237.619%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.993%
Denali Therapeutics Inc. 330.53 Million USD 99.785%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 95.649%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 73.77%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -365.132%
Carisma Therapeutics, Inc. 14.91 Million USD 95.248%
Unicycive Therapeutics, Inc. 675 Thousand USD -5.037%
OmniAb, Inc. 34.16 Million USD 97.925%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 96.664%
Lipocine Inc. -2.85 Million USD 124.87%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 68.334%
G1 Therapeutics, Inc. 82.51 Million USD 99.141%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.18%
Ocugen, Inc. 6.03 Million USD 88.254%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 38.668%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 98.035%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 88.188%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 65.228%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.939%
Agios Pharmaceuticals, Inc. 26.82 Million USD 97.357%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.878%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 94.371%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD -48.637%
Iterum Therapeutics plc - USD -Infinity%